January 5, 2016
Suven’s products gets three patent grants; from Canada, ARIPO, and South Korea
Suven Life Sciences Ltd has announced that the grand of one product patent from Canada, one from ARIPO and one from South Korea corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2030.